Chiome Bioscience Inc.
Notice on the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Adjustment Provisions, 23rd Issue
Disclosure of the exercise status of stock acquisition rights on a monthly basis. The target month is July 2026, with 2,209,800 shares issued, an exercise rate of 16.24%, and total unexercised remaining shares reduced to 7,137. Exercise dates span multiple days from July 1 to July 31.
Key Figures
- Target Month Issued Shares: 2,209,800 shares
- Target Month Exercise Rate: 16.24%
- Unexercised Remaining Shares: 7,137 shares
AI要約
Overview of Results
This disclosure is an update on the monthly exercise status of the 23rd stock acquisition rights (with exercise price adjustment provisions). The number of issued shares is 2,209,800, the total number exercised this month is not disclosed, but the exercise rate is 16.24%. Unexercised remaining shares have decreased significantly from the previous month, indicating impacts on liquidity and potential dilution.
Impact on Shareholders / Outlook
The decline in unexercised remaining shares may help curb potential future dilution. However, since exercise dates involve monthly dispersion of share issuances, future exercise trends could cause changes in the number of shares and the dilution rate.
Kaio Medical Science Co., Ltd.
Company overview · Stock price · Financial data · All IR
